In this post hoc study, we find that type 2 diabetes and obesity are associated with increased fasting amino acid levels, and that an intravenous glucagon infusion of 4 ng/kg/min acutely lowers circulating amino acid concentrations in both individuals with and without type 2 diabetes and with and without obesity. This evidence concerns the gene GCG and Obesity.